An official website of the United States government
NIH Guide: Weekly Index for June 10, 2022
Weekly NIH Guide Notices
June 10, 2022
Policy Notices
-
Notice to Extend PA-18-794
(NOT-HS-22-016)Agency for Healthcare Research and Quality
-
Notice to Extend PA-18-795
(NOT-HS-22-017)Agency for Healthcare Research and Quality
General Notices
-
Notice of Preapplication Webinar for RFA-CA-22-016, Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)
(NOT-CA-22-089)National Cancer Institute
-
Notice of Correction to Eligibility for RFA-HD-23-002 NICHD Neonatal Research Network (NRN): Clinical Centers (UG1 Clinical Trial Optional)
(NOT-HD-22-024)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Solicitation of Nominations for the 2022 National Human Genome Research Institutes Outstanding Award for Enhancing Diversity, Equity, Inclusion, and Accessibility in the Genomics Workforce
(NOT-HG-22-014)National Human Genome Research Institute
-
Notice of Change to RFA-OD-22-003, "Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)"
(NOT-OD-22-155)Office of Disease Prevention
-
Notice of Pre-Application Webinar: Harnessing Data Science for Health Discovery and Innovation in Africa: Research Education Program (UE5 Clinical Trial Not Allowed) & Partnership for Innovation Research Projects (U01 Clinical Trial Not Allowed)
(NOT-RM-22-015)Office of Strategic Coordination (Common Fund)
-
Request for Information: Inviting comments and suggestions from stakeholders on Pediatric Medical Devices Public-Private Partnership
(NOT-EB-22-008)National Institute of Biomedical Imaging and BioengineeringEunice Kennedy Shriver National Institute of Child Health and Human Development
-
Request for Information (RFI): NINDS/NICHD Workshop on Cerebral Palsy Research
(NOT-NS-22-105)National Institute of Neurological Disorders and Stroke
Notice of Changes to Funding Opportunities
-
Notice of Change in Funding Opportunity RFA-RM-22-015, IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed)
(NOT-RM-22-014)Office of Strategic Coordination (Common Fund)
Notices of Special Interest
-
Notice of Special Interest (NOSI): Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities (R43/R44)
(NOT-HD-22-009)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Special Interest (NOSI): Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
(NOT-OD-22-137)Office of the Director, NIHNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesJohn E. Fogarty International CenterNational Institute on Minority Health and Health DisparitiesNational Center for Advancing Translational Sciences
-
Notice of Special Interest: Administrative Supplements to NIH-funded T32 and TL1 Training Grants to Better Integrate Behavioral and Social Sciences (BSS) with other Health-Related Sciences
(NOT-OD-22-141)Office of Behavioral and Social Sciences ResearchNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Environmental Health SciencesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Institute of Nursing ResearchNational Center for Advancing Translational SciencesNational Center for Complementary and Integrative HealthNational Center for Advancing Translational Sciences
Funding Opportunities
-
Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
(PAR-22-181)National Institute of Neurological Disorders and StrokeNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Eye InstituteNational Institute of Mental HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): January 7, 2025
-
Measures and Methods for Research on Family Caregivers for People Living with Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Not Allowed)
(RFA-AG-23-022)National Institute on AgingApplication Receipt Date(s): October 20, 2022
-
Measures and Methods for Research on Family Caregivers for People Living with Alzheimers Disease and Related Dementias (AD/ADRD) (R21 Clinical Trial Not Allowed)
(RFA-AG-23-023)National Institute on AgingApplication Receipt Date(s): October 20, 2022
-
Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
(RFA-DA-23-019)National Institute on Drug AbuseApplication Receipt Date(s): November 14, 2022
-
Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
(RFA-DA-23-020)National Institute on Drug AbuseApplication Receipt Date(s): November 14, 2022
-
Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C - Clinical Trial Not Allowed)
(RFA-DK-22-001)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): October 26, 2022
-
Multidisciplinary K12 Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional)
(RFA-DK-22-006)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): October 27, 2022
-
Limited Competition for the Continuation of HiLo: Pragmatic Trial of Higher versus Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis Clinical Centers (UH3- Clinical Trial Required)
(RFA-DK-22-501)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): October 19, 2022
-
Limited Competition for the Continuation of the NIDDK Diabetic Foot Consortium - Clinical Research Units (U01 Clinical Trial Optional)
(RFA-DK-22-509)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): August 17, 2022
-
Research Coordinating Center to Support Climate Change and Health Community of Practice (U24 Clinical Trial Not Allowed)
(RFA-ES-22-003)National Institute of Environmental Health SciencesNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Nursing ResearchJohn E. Fogarty International CenterNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): August 25, 2022
-
Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed)
(RFA-NS-22-051)National Institute of Neurological Disorders and StrokeNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Eye InstituteNational Human Genome Research InstituteApplication Receipt Date(s): August 10, 2022
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster